Olfactory bulb enlargement in neurofibromatosis type 1: report of a novel finding.
Alessandra D'AmicoMartina Di StasiLorenzo UggaTeresa PerilloClaudia SantoroDaniela MelisPublished in: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2021)
Neurofibromatosis type 1 (NF1) is a genetic autosomal dominant disease caused by mutation of the protein neurofibromin, a regulator of cell growth. The most frequent intracranial findings are unidentified bright objects (UBOs), thickening of the corpus callosum, sphenoid wing dysplasia, cerebral vasculopathy, optic and non-optic pilocytic astrocytomas, and plexiform neurofibromas. We report two cases of NF1 patients with asymptomatic olfactory bulbs (OBs) enlargement depicted with Magnetic Resonance Imaging (MRI). To the best of our knowledge, this finding has not been reported in the scientific literature so far. We hypothesize that olfactory bulbs enlargement may have a pathogenetic nature like that of the UBOs as in one of our patients there was spontaneous regression during follow-up. The olfactory bulbs enlargement expands the broad neuroradiological spectrum of finding of NF1. More reports are required to better understand incidence, pathogenesis, and clinical behavior of olfactory bulbs enlargement in NF1 patients.
Keyphrases
- magnetic resonance imaging
- end stage renal disease
- signaling pathway
- lps induced
- newly diagnosed
- chronic kidney disease
- ejection fraction
- oxidative stress
- prognostic factors
- healthcare
- systematic review
- nuclear factor
- peritoneal dialysis
- emergency department
- computed tomography
- optical coherence tomography
- inflammatory response
- risk factors
- immune response
- transcription factor
- dna methylation
- patient reported
- subarachnoid hemorrhage
- blood brain barrier
- binding protein
- adverse drug